Skip to main content
Clinical Trials/IRCT20180205038626N12
IRCT20180205038626N12RecruitingPhase 2

Evaluation of the effects of rice bran oil capsule on glycemic indices, antioxidant and inflammatory indicators patients with type 2 diabetes: Double-blinded randomized clinical trial

Rasht University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 70 years (—)
Sex
All

Inclusion Criteria

  • Patients with an age range of 20 to 70 years
  • Patients diagnosed with type 2 diabetes under drug therapy
  • Serum glucose greater than 110 mg/dL
  • Hemoglobin A1C maximum 9%
  • Body mass index in the range of 25-30
  • Not using vitamin and mineral supplements, antioxidants, fiber supplements, omega-3
  • No history of kidney disease, kidney stones, digestive diseases, gallstones, and autoimmune diseases
  • No current consumption of alcohol
  • Not taking insulin

Exclusion Criteria

  • Change in the patient's disease treatment plan during the study
  • Changing the type of drugs used, effective factors studied
  • Reluctance to continue the study or cause any dissatisfaction regarding the taste of the oil or participation in the study

Investigators

Sponsor
Rasht University of Medical Sciences

Similar Trials